Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.
Transform life sciences with AI-driven data strategies for impactful insights across the product lifecycle.
Learn about our data strategy and analytics services for pharmaceutical companies in the life science industry.
Mobile navigation menu modal
Explore our latest insights and perspectives in these life science resources, news articles, and events.
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Future-proofed data strategy with Putnam: gaps identified, vendors vetted, leading to a first US multi-source tokenized DB.
Built a data gateway aligning insights with market realities to map complex patient journeys and power ML-driven HCP engagement.
Built a first in US data platform combining claims data, improving patient coverage by 30% and enriching insights.
Driving medical value through data-driven insights & strategic interventions to enhance patient care & establish thought leadership.
A biopharma client with an early clinical stage compound, showing efficacy across multiple neuropsychiatric conditions, wished to prioritize...
A large biopharma client objective aimed to optimize its omnichannel (OC) approach for HCP and patient Medical Education...
A top biopharma client wanted to understand diagnosis and treatment patterns for a rare respiratory disease only recently associated as a sequela....
A rare disease research consortium sought to identify barriers to adoption of AI-enabled, point-of-care diagnostic decision support tools..
A top biopharma client was in early-stage clinical development of an asset that showed efficacy in all-comers with the target disease, but even...
Designing a new GTM model for an ambitious upcoming oncology launch.
Looking to get in touch with an expert or team member?
Tell us how we can help.
